Filing exhibits
- 8-K Current report
- 10.1 First Amendment to Exclusive License Agreement Between Inmune Bio Inc. and Immune Ventures LLC Dated April 17, 2023
- 10.2 Second Amendment to Exclusive License Agreement by and Between the University of Pittsburgh of the Commonwealth System of Higher Education and Immune Ventures, LLC Dated April 17, 2023
- 99.1 XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer’s Disease
- Download Excel data file
- View Excel data file
Table of Contents